Log In
Print
BCIQ
Print
Print this Print this
 

BD0801 (APX003)

  Manage Alerts
Collapse Summary General Information
Company Apexigen Inc.
DescriptionHumanized mAb directed against VEGF
Molecular Target Vascular endothelial growth factor (VEGF)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner

Simcere Pharmaceutical Group


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today